Stockreport

Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Larimar Therapeutics, Inc.  (LRMR) 
PDF BALA CYNWYD, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing t [Read more]